These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy. van der Heijde D, Burmester G, Melo-Gomes J, Codreanu C, Mola EM, Pedersen R, Freundlich B, Chang DJ, Etanercept Study 400 Investigators. Ann Rheum Dis; 2008 Feb; 67(2):182-8. PubMed ID: 17728331 [Abstract] [Full Text] [Related]
4. Patients with moderate rheumatoid arthritis (RA) achieve better disease activity states with etanercept treatment than patients with severe RA. Keystone E, Freundlich B, Schiff M, Li J, Hooper M. J Rheumatol; 2009 Mar; 36(3):522-31. PubMed ID: 19228659 [Abstract] [Full Text] [Related]
6. Clinical and ultrasound-based composite disease activity indices in rheumatoid arthritis: results from a multicenter, randomized study. Mandl P, Balint PV, Brault Y, Backhaus M, D'Agostino MA, Grassi W, van der Heijde D, de Miguel E, Wakefield RJ, Logeart I, Dougados M. Arthritis Care Res (Hoboken); 2013 Jun; 65(6):879-87. PubMed ID: 23213004 [Abstract] [Full Text] [Related]
7. Efficacy and safety of etanercept 50 mg twice a week in patients with rheumatoid arthritis who had a suboptimal response to etanercept 50 mg once a week: results of a multicenter, randomized, double-blind, active drug-controlled study. Weinblatt ME, Schiff MH, Ruderman EM, Bingham CO, Li J, Louie J, Furst DE. Arthritis Rheum; 2008 Jul; 58(7):1921-30. PubMed ID: 18576334 [Abstract] [Full Text] [Related]
8. Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement. Wechalekar MD, Lester S, Proudman SM, Cleland LG, Whittle SL, Rischmueller M, Hill CL. Arthritis Rheum; 2012 May; 64(5):1316-22. PubMed ID: 22135142 [Abstract] [Full Text] [Related]
17. Adsorptive granulocyte/monocyte apheresis for the treatment of refractory rheumatoid arthritis: an open pilot multicentre trial. Sanmartí R, Marsal S, Valverde J, Casado E, Lafuente R, Kashiwagi N, Rodriguez-Cros JR, Erra A, Reina D, Gratacós J. Rheumatology (Oxford); 2005 Sep; 44(9):1140-4. PubMed ID: 15927997 [Abstract] [Full Text] [Related]
19. Can remission in rheumatoid arthritis be assessed without laboratory tests or a formal joint count? possible remission criteria based on a self-report RAPID3 score and careful joint examination in the ESPOIR cohort. Castrejón I, Dougados M, Combe B, Guillemin F, Fautrel B, Pincus T. J Rheumatol; 2013 Apr; 40(4):386-93. PubMed ID: 23378463 [Abstract] [Full Text] [Related]